T-Knife Therapeutics
Germany - BerlinBiotechnology
Focus: T-Knife Therapeutics is a Berlin-based biotech company developing TCR (T-cell receptor) engineered cell therapies for solid tumors, currently in early clinical stage with one Phase 1/2 program.
Profile data last refreshed 5h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
3+2 this month
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Should You Work at T-Knife Therapeutics?
AI assessmentSuitable for early-career scientists or engineers seeking deep TCR expertise and high technical leverage, but unsuitable for those prioritizing job security or clear advancement pathways.
Why Work Here
- Ground-floor opportunity in cutting-edge TCR cell therapy, a differentiated modality with significant clinical potential in solid tumors where CAR-T has struggled.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR
Advanced Solid TumorsClinical Trials (1)
NCT05430555A Phase 1/ 2, First-in-Human, Open-Label, Accelerated-Titration, Two-Part Clinical Trial of TK-8001 in Patients With HLA-A*02:01 Genotype and Advanced-Stage/ Metastatic MAGE-A1+ Solid Tumors
Phase 1/2Help build intelligence for T-Knife Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.